How Allergan went from a tiny but beloved Southern California eye care company to a dealmaking machine to falling out of grace with investors (AGN)

Reuters It’s been a rocky year for Allergan, the pharmaceutical company best known for making Botox.  Investors have been unhappy with Allergan’s stock performance over the last year, and some have expressed interest in seeing the pharma company explore splitting up. On Wednesday, Allergan announced it plans to sell its women’s health and infectious disease businesses. The […]

Investors are frustrated with Botox-maker Allergan — and its CEO says it’s ‘deep into the process’ of figuring out what to do next (AGN)

Reuters Allergan said Monday during its first-quarter earnings call that it’s “deep into the process” of its strategic review of the company amid its stock price slipping over the past year.  Allergan CEO Brent Saunders outlined five possible approaches the company’s exploring, which include divesting certain businesses.  Investors, Saunders said, are frustrated, and some of […]

Judge throws out Allergan patent, slams company’s Native American deal

Enlarge / Allergan’s R&D and global production site in Pringy, France. (credit: JEAN-PIERRE CLATOT/AFP/Getty Images) A federal judge ruled today that patents protecting Allergan’s $ 1.5 billion blockbuster dry-eye drug, Restasis, are invalid due to obviousness. The international drug company’s stock dropped about five percent on the news. The ruling by US Circuit Judge William […]

‘That should be illegal’: Lawmakers are taking aim at pharma giant Allergan over an unusual deal with a Native American tribe (AGN)

Reuters In September, Allergan struck an unusual deal with the Saint Regis Mohawk Tribe to transfer patents of the eye drug Restasis, a move that gives the drug sovereign immunity from certain patent challenges.  The goal is to protect the blockbuster drug from generic competition before its patents run out in 2024.  Lawmakers aren’t too happy […]